Speciality Medicines Limited IPO
BSE SME
₹ 248000
/2000 Shares
*Min Investment
20 Mar, 2026
Open Date24 Mar, 2026
Close Date25 Mar, 2026
Allotment Date30 Mar, 2026
Listing DateSpeciality Medicines IPO Issue Details
- Issue Price ₹117-124 per equity share
- Face Value ₹10 Per Equity Share
- Total Issue Size 23,50,000 shares(aggregating up to ₹29.14 crore)
- Fresh Share 23,50,000 shares(aggregating up to ₹29.14 crore)
- Listing at BSE SME
- Lead Manager UNISTONE CAPITAL PRIVATE LIMITED
- Registrar Skyline Financial Services Pvt.Ltd.
Market Lot Size
Investors can bid for a minimum of 2,000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual (min) | 2 | 2,000 | ₹2,48,000 |
| Individual(max) | 2 | 2,000 | ₹2,48,000 |
| SHNI(min) | 3 | 3,000 | ₹3,72,000 |
| SHNI(max) | 8 | 8,000 | ₹9,92,000 |
| BHNI(min) | 9 | 9,000 | ₹11,16,000 |
Speciality Medicines IPO Documents
Speciality Medicines IPO Details
Speciality Medicines Limited IPO is an SME IPO, priced at ₹117-124 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the BSE SME platform. The IPO comprises a total issue of 23,50,000 equity shares, aggregating up to ₹29.14 crores..
The IPO bidding window is open from Mar 20, 2026 to Mar 24, 2026. The allotment is expected to be finalized on Mar 25, 2026, and the tentative listing date is Mar 30, 2026.
The minimum lot size for Individual investors is 2,000 shares, with a minimum investment of ₹2,48,000.
UNISTONE CAPITAL PRIVATE LIMITED is acting as the lead manager to the issue. The registrar of the IPO is Skyline Financial Services Pvt.Ltd., and
Read More
Speciality Medicines Valuations
Speciality Medicines Company Financials
| 31-Mar-25 | 31-Mar-24 | 31-Mar-23 |
|---|
About Speciality Medicines Company
Incorporated in the year 2021, Speciality Medicines Limited is a company involved in the marketing and distribution of finished formulations of speciality medicines across domestic and international markets. The company’s product portfolio includes a wide range of speciality pharmaceutical finished formulations products in various dosage forms, including tablets, capsules, creams, syrups, eye drops, gels, infusions, inhalers, injections, nasal sprays, ointments, ophthalmic solutions, oral solutions, sachets, and suspensions.
The company operates in the following ways: contract manufacturing of finished formulations for international markets and marketing and distribution of sourced specialty pharmaceutical products. The company has expanded to the international market with registered/pending products in countries like Jordan, Ethiopia, Uganda, Peru, and Namibia. The company’s distribution network has established strong relationships with over 20 states in India and over 35 countries worldwide. As of March 31, 2025, the company has 1 product registered overseas and 60 products in the registration process across 5 countries, generating revenue.
As of August 31, 2025, the company had a total of 18 permanent employees in various departments.
Speciality Medicines - Promoter(s)
Parth B Goyani
Goyani Sumit Babubhai
Pre Issue Share Holding : 59.28%
Post Issue Share Holding : 43.44%
Speciality Medicines IPO - Issue Objectives
Setting up of Research and Development (R&D) Center
Product registration in the international markets
Repayment/ Prepayment, in full or part, of certain borrowings availed by the Company
To Meet Working Capital Requirements
General Corporate Purpose
Contact Details
Speciality Medicines
913, One World West, S. No. 396, FP 119, Village - Vejalpur, Ahmadabad City, Ahmedabad, Gujarat, India - 380051.
+91 22 4604 5344
Registrar Contact Details
Skyline Financial Services Private Ltd
02228511022
Speciality Medicines IPO - FAQs
Ans. Speciality Medicines Limited IPO is a SME IPO. The issue is priced at ₹117-124 per equity share. The minimum order quantity is 1000 Shares. The IPO opens on Mar 20, 2026, and closes on Mar 24, 2026. Skyline Financial Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Ans. The Speciality Medicines Limited IPO opens on Mar 20, 2026 and closes on Mar 24, 2026.
Ans. You can track the real-time subscription numbers using the links below:
Ans. The size of Speciality Medicines Limited IPO is 23,50,000 shares(agg. up to ₹29.14 Cr).
Ans. The Speciality Medicines Limited IPO price band is set between ₹117-124 per equity share.
Ans. To apply for Speciality Medicines Limited IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Speciality Medicines Limited IPO in the List of IPOs
- - Press Apply Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Speciality Medicines Limited IPO is Mar 25, 2026.
Ans. The Speciality Medicines Limited IPO will be listed on Mar 30, 2026.
Ans. Follow the steps to check the Speciality Medicines Limited IPO allotment status online.
